{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:19Z","timestamp":1793367139867,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejso.2026.112128","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:44:57Z","timestamp":1789195497000},"page":"112128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Margin positivity and re-excision after breast-conserving surgery following neoadjuvant chemotherapy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8952-0462","authenticated-orcid":false,"given":"Niamh","family":"Keating","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-4775","authenticated-orcid":false,"given":"Jane","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Evoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6045-0124","authenticated-orcid":false,"given":"Claire L.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2488-095X","authenticated-orcid":false,"given":"Damian","family":"McCartan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S.","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-8189","authenticated-orcid":false,"given":"Michael R.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112128_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112128_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib3","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib4","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib5","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902","volume":"19","author":"van der Hage","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","article-title":"Society of surgical oncology\u2013American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"32","author":"Moran","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41379-020-00714-5","article-title":"Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer","volume":"34","author":"Pastorello","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2026.112128_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/djs528","article-title":"Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy","volume":"105","author":"Marinovich","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2026.112128_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00268-020-05383-8","article-title":"The impact of neoadjuvant chemotherapy on margin Re-excision in breast-conserving surgery","volume":"44","author":"Devane","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2026.112128_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-017-4598-5","article-title":"Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes","volume":"168","author":"Volders","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.112128_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/bjs\/znac131","article-title":"Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study","volume":"109","author":"Fatayer","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.112128_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2026.112128_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2026.112128_bib14","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1245\/s10434-018-6702-4","article-title":"Margins in breast-conserving surgery after neoadjuvant therapy","volume":"25","author":"Choi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib15","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1245\/s10434-013-2921-x","article-title":"Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique","volume":"20","author":"Donker","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mds475","article-title":"The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy","volume":"24","author":"Gobardhan","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000544904","article-title":"Clinicopathological factors affecting positive margins after breast-conserving surgery: a comparative study of Low- and high-volume hospitals","volume":"20","author":"Makineli","year":"2025","journal-title":"Breast Care"},{"key":"10.1016\/j.ejso.2026.112128_bib18","article-title":"Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy","volume":"50","author":"Ploumen","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-023-07192-8","article-title":"Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome","volume":"204","author":"van Hemert","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.112128_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070346","article-title":"Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis","volume":"378","author":"Bundred","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2026.112128_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ejso.2016.02.252","article-title":"Neoadjuvant chemotherapy in breast-conserving surgery - consequences on margin status and excision volumes: a nationwide pathology study","volume":"42","author":"Volders","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112128_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-017-4232-6","article-title":"Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival","volume":"164","author":"Vos","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.112128_bib23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamasurg.2022.4118","article-title":"Association of residual ductal carcinoma in situ with breast cancer recurrence in the neoadjuvant I-SPY2 trial","volume":"157","author":"Osdoit","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2026.112128_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/healthcare11050746","article-title":"Invasive lobular carcinoma: a review of imaging modalities with special focus on pathology concordance","volume":"11","author":"Pereslucha","year":"2023","journal-title":"Healthcare (Basel)"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832600747X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832600747X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:44:35Z","timestamp":1793364275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832600747X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S074879832600747X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112128","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Margin positivity and re-excision after breast-conserving surgery following neoadjuvant chemotherapy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112128"}}